Example of Journal of Neuro-Oncology format
Recent searches

Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format Example of Journal of Neuro-Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Journal of Neuro-Oncology — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Neurology (clinical) #62 of 343 up up by 16 ranks
Neurology #32 of 156 up up by 14 ranks
Oncology #81 of 340 up up by 26 ranks
Cancer Research #78 of 207 up up by 15 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 1227 Published Papers | 7850 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 20/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 9.5
SJR: 1.729
SNIP: 1.739
open access Open Access

SAGE

Quality:  
High
CiteRatio: 7.3
SJR: 1.684
SNIP: 1.763
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 6.8
SJR: 1.651
SNIP: 1.671
open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.3
SJR: 1.395
SNIP: 2.063

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

3.267

4% from 2018

Impact factor for Journal of Neuro-Oncology from 2016 - 2019
Year Value
2019 3.267
2018 3.129
2017 3.06
2016 2.98
graph view Graph view
table view Table view

6.4

16% from 2019

CiteRatio for Journal of Neuro-Oncology from 2016 - 2020
Year Value
2020 6.4
2019 5.5
2018 5.2
2017 5.2
2016 5.4
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 4% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 16% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.256

2% from 2019

SJR for Journal of Neuro-Oncology from 2016 - 2020
Year Value
2020 1.256
2019 1.228
2018 1.194
2017 1.168
2016 1.167
graph view Graph view
table view Table view

1.26

15% from 2019

SNIP for Journal of Neuro-Oncology from 2016 - 2020
Year Value
2020 1.26
2019 1.093
2018 1.099
2017 0.986
2016 1.05
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 2% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 15% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Journal of Neuro-Oncology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Journal of Neuro-Oncology

The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. More than any other field of oncology, cancer of the central nervous system req...... Read More

Clinical Neurology

Oncology

Cancer Research

Medicine

i
Last updated on
20 Jun 2020
i
ISSN
0167-594X
i
Impact Factor
High - 1.232
i
Acceptance Rate
20%
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1007/S11060-010-0389-0
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

Abstract:

Therapy options at the time of recurrence of glioblastoma multiforme are often limited. We investigated whether treatment with a new intratumoral thermotherapy procedure using magnetic nanoparticles improves survival outcome. In a single-arm study in two centers, 66 patients (59 with recurrent glioblastoma) received neuronavi... Therapy options at the time of recurrence of glioblastoma multiforme are often limited. We investigated whether treatment with a new intratumoral thermotherapy procedure using magnetic nanoparticles improves survival outcome. In a single-arm study in two centers, 66 patients (59 with recurrent glioblastoma) received neuronavigationally controlled intratumoral instillation of an aqueous dispersion of iron-oxide (magnetite) nanoparticles and subsequent heating of the particles in an alternating magnetic field. Treatment was combined with fractionated stereotactic radiotherapy. A median dose of 30 Gy using a fractionation of 5 × 2 Gy/week was applied. The primary study endpoint was overall survival following diagnosis of first tumor recurrence (OS-2), while the secondary endpoint was overall survival after primary tumor diagnosis (OS-1). Survival times were calculated using the Kaplan–Meier method. Analyses were by intention to treat. The median overall survival from diagnosis of the first tumor recurrence among the 59 patients with recurrent glioblastoma was 13.4 months (95% CI: 10.6–16.2 months). Median OS-1 was 23.2 months while the median time interval between primary diagnosis and first tumor recurrence was 8.0 months. Only tumor volume at study entry was significantly correlated with ensuing survival (P < 0.01). No other variables predicting longer survival could be determined. The side effects of the new therapeutic approach were moderate, and no serious complications were observed. Thermotherapy using magnetic nanoparticles in conjunction with a reduced radiation dose is safe and effective and leads to longer OS-2 compared to conventional therapies in the treatment of recurrent glioblastoma. read more read less

Topics:

Primary tumor (53%)53% related to the paper, External beam radiotherapy (52%)52% related to the paper, Dose fractionation (51%)51% related to the paper, Radiation therapy (50%)50% related to the paper
View PDF
1,090 Citations
open accessOpen access Journal Article DOI: 10.1007/S11060-013-1084-8
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.
Johnny C. Akers1, David D. Gonda1, Ryan Y. Kim1, Bob S. Carter1, Clark C. Chen1

Abstract:

Recent studies suggest both normal and cancerous cells secrete vesicles into the extracellular space. These extracellular vesicles (EVs) contain materials that mirror the genetic and proteomic content of the secreting cell. The identification of cancer-specific material in EVs isolated from the biofluids (e.g., serum, cerebro... Recent studies suggest both normal and cancerous cells secrete vesicles into the extracellular space. These extracellular vesicles (EVs) contain materials that mirror the genetic and proteomic content of the secreting cell. The identification of cancer-specific material in EVs isolated from the biofluids (e.g., serum, cerebrospinal fluid, urine) of cancer patients suggests EVs as an attractive platform for biomarker development. It is important to recognize that the EVs derived from clinical samples are likely highly heterogeneous in make-up and arose from diverse sets of biologic processes. This article aims to review the biologic processes that give rise to various types of EVs, including exosomes, microvesicles, retrovirus like particles, and apoptotic bodies. Clinical pertinence of these EVs to neuro-oncology will also be discussed. read more read less

Topics:

Microvesicles (58%)58% related to the paper
View PDF
990 Citations
Journal Article DOI: 10.1023/A:1005845307160
Vascular endothelial growth factor

Abstract:

Vascular endothelial growth factor (VEGF) is a hypoxia-inducible angiogenesis and vascular permeability factor which is expressed in high amounts in perinecrotic palisading cells in human glioblastomas. In vitro VEGF gene expression is enhanced approximately ten times by hypoxia. Current evidence suggests, that hypoxia is als... Vascular endothelial growth factor (VEGF) is a hypoxia-inducible angiogenesis and vascular permeability factor which is expressed in high amounts in perinecrotic palisading cells in human glioblastomas. In vitro VEGF gene expression is enhanced approximately ten times by hypoxia. Current evidence suggests, that hypoxia is also the driving force for VEGF gene expression in glioblastoma cells in vivo and represents the most important trigger for tumor angiogenesis and edema. Our approaches to inhibit tumor angiogenesis and edema formation in glioblastoma patients will concentrate on the disruption of VEGF/VEGF receptor signal transduction pathway in vivo. read more read less

Topics:

Vascular endothelial growth factor (65%)65% related to the paper, Vascular endothelial growth factor B (65%)65% related to the paper, Angiogenesis (65%)65% related to the paper, Vascular permeability (55%)55% related to the paper, Neovascularization (54%)54% related to the paper
982 Citations
open accessOpen access Journal Article DOI: 10.1007/S11060-010-0386-3
Epidemiology and etiology of meningioma.
Joseph L. Wiemels1, Margaret Wrensch1, Elizabeth B. Claus2, Elizabeth B. Claus3

Abstract:

Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrations, their intracranial location often leads to serious and potentially lethal consequences. They are the most frequently diagnosed primary brain tumor accounting for 33.8% of all primary brain and central nervous system tumor... Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrations, their intracranial location often leads to serious and potentially lethal consequences. They are the most frequently diagnosed primary brain tumor accounting for 33.8% of all primary brain and central nervous system tumors reported in the United States between 2002 and 2006. Inherited susceptibility to meningioma is suggested both by family history and candidate gene studies in DNA repair genes. People with certain mutations in the neurofibromatosis gene (NF2) have a very substantial increased risk for meningioma. High dose ionizing radiation exposure is an established risk factor for meningioma, and lower doses may also increase risk, but which types and doses are controversial or understudied. Because women are twice as likely as men to develop meningiomas and these tumors harbor hormone receptors, an etiologic role for hormones (both endogenous and exogenous) has been hypothesized. The extent to which immunologic factors influence meningioma etiology has been largely unexplored. Growing emphasis on brain tumor research coupled with the advent of new genetic and molecular epidemiologic tools in genetic and molecular epidemiology promise hope for advancing knowledge about the causes of intra-cranial meningioma. In this review, we highlight current knowledge about meningioma epidemiology and etiology and suggest future research directions. read more read less

Topics:

Meningioma (55%)55% related to the paper, Brain tumor (54%)54% related to the paper
View PDF
858 Citations
Journal Article DOI: 10.1007/S11060-004-8093-6
Brain metastases: epidemiology and pathophysiology
Igor T. Gavrilovic1, Jerome B. Posner1

Abstract:

Metastases are the most common tumors of the central nervous system (CNS), but cancer databases are often incomplete leading to underestimation of the incidence of even symptomatic brain metastases. Brain imaging studies are not routinely performed on neurologically asymptomatic cancer patients and autopsy studies are outdate... Metastases are the most common tumors of the central nervous system (CNS), but cancer databases are often incomplete leading to underestimation of the incidence of even symptomatic brain metastases. Brain imaging studies are not routinely performed on neurologically asymptomatic cancer patients and autopsy studies are outdated. Furthermore, while incidence rates for cancers are stable and mortality is decreasing due to earlier detection and better therapy, the incidence of brain metastases appears to be increasing. The pathophysiology of brain metastases is a complex multistage process, mediated by molecular mechanisms; from the primary organ, cancer cells must transform, grow and be transported to the CNS where they can lay dormant for various lengths of time before invading and growing further. Understanding the pathophysiology of brain metastases is of great importance, because it may lead to the development of more efficient therapies to combat brain tumor growth or to possibly make the CNS an undesirable environment for tumor progression. read more read less

Topics:

Brain metastasis (62%)62% related to the paper, Brain tumor (54%)54% related to the paper, Metastasis (54%)54% related to the paper, Primary central nervous system lymphoma (53%)53% related to the paper, Cancer (51%)51% related to the paper
791 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Journal of Neuro-Oncology.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Journal of Neuro-Oncology format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Journal of Neuro-Oncology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Journal of Neuro-Oncology guidelines and auto format it.

2. Do you follow the Journal of Neuro-Oncology guidelines?

Yes, the template is compliant with the Journal of Neuro-Oncology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Journal of Neuro-Oncology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Journal of Neuro-Oncology citation style.

4. Can I use the Journal of Neuro-Oncology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Journal of Neuro-Oncology.

5. Can I use a manuscript in Journal of Neuro-Oncology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Journal of Neuro-Oncology that you can download at the end.

6. How long does it usually take you to format my papers in Journal of Neuro-Oncology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Journal of Neuro-Oncology.

7. Where can I find the template for the Journal of Neuro-Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Neuro-Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Journal of Neuro-Oncology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Journal of Neuro-Oncology an online tool or is there a desktop version?

SciSpace's Journal of Neuro-Oncology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Journal of Neuro-Oncology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Journal of Neuro-Oncology?”

11. What is the output that I would get after using Journal of Neuro-Oncology?

After writing your paper autoformatting in Journal of Neuro-Oncology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Journal of Neuro-Oncology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Journal of Neuro-Oncology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Journal of Neuro-Oncology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Journal of Neuro-Oncology?

The 5 most common citation types in order of usage for Journal of Neuro-Oncology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Journal of Neuro-Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Journal of Neuro-Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Journal of Neuro-Oncology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Journal of Neuro-Oncology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Journal of Neuro-Oncology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template